Segment Information (Tables)

6 Months Ended

Dec. 27, 2014

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Three Months Ended							Balance at December 27, 2014
	December 27, 2014
	Net Sales		Operating Income (Loss)			Amortization of Intangibles		Total Assets
Consumer Healthcare	$	529.6	$	74.9		$	8.7	$	6,310.9
Nutritionals	130.6		7.2			7.2		1,057.2
Rx Pharmaceuticals	276.6		109.7			18.0		2,612.9
API	30.0		7.4			0.5		255.2
Specialty Sciences	86.6		9.5			72.8		6,135.6
Other	18.3		1.1			0.4		88.9
Unallocated expenses	—		(25.4		)	—		—
Total	$	1,071.7	$	184.4		$	107.6	$	16,460.7
	Three Months Ended							Balance at December 28, 2013
	December 28, 2013
	Net Sales		Operating Income (Loss)			Amortization of Intangibles		Total Assets
Consumer Healthcare	$	536.3	$	89.5		$	5.3	$	2,345.5
Nutritionals	139.7		13.3			7.4		1,014.0
Rx Pharmaceuticals	246.6		100.4			21.5		1,940.1
API	30.0		8.2			0.5		284.7
Specialty Sciences	7.4		(19.0		)	8.7		8,023.8
Other	19.0		0.6			0.4		104.7
Unallocated expenses	—		(106.4		)	—		—
Total	$	979.0	$	86.6		$	43.8	$	13,712.8

	Six Months Ended
	December 27, 2014
	Net Sales		Operating Income (Loss)			Amortization of Intangibles
Consumer Healthcare	$	1,022.9	$	140.2		$	17.4
Nutritionals	255.8		15.7			14.4
Rx Pharmaceuticals	471.2		174.4			35.0
API	54.8		14.4			1.0
Specialty Sciences	178.4		24.4			145.6
Other	40.0		2.0			0.8
Unallocated expenses	—		(49.6		)	—
Total	$	2,023.1	$	321.5		$	214.2
	Six Months Ended
	December 28, 2013
	Net Sales		Operating Income (Loss)			Amortization of Intangibles
Consumer Healthcare	$	1,074.8	$	179.5		$	10.6
Nutritionals	268.7		21.0			14.7
Rx Pharmaceuticals	450.2		183.5			37.7
API	73.2		30.6			1.0
Specialty Sciences	7.4		(19.0		)	8.7
Other	38.1		1.8			0.9
Unallocated expenses	—		(131.2		)	—
Total	$	1,912.4	$	266.2		$	73.6